SGLT2i, GLP-1 RA Prescribing Lower for Minority Patients - R

Second study shows low rate of SGLT2i prescribing even among patients with indications for therapy

Related Keywords

Chicago , Illinois , United States , Oakland , California , American , Kaiser Permanente , Luisa Rodriguez , Cardiometabolic Health , American Heart Association Epidemiology , Johns Hopkins University In Baltimore , Healthday News , Johns Hopkins University ,